PEPFAR's annual planning process is done either at the country (COP) or regional level (ROP).
PEPFAR's programs are implemented through implementing partners who apply for funding based on PEPFAR's published Requests for Applications.
Since 2010, PEPFAR COPs have grouped implementing partners according to an organizational type. We have retroactively applied these classifications to earlier years in the database as well.
Also called "Strategic Areas", these are general areas of HIV programming. Each program area has several corresponding budget codes.
Specific areas of HIV programming. Budget Codes are the lowest level of spending data available.
Expenditure Program Areas track general areas of PEPFAR expenditure.
Expenditure Sub-Program Areas track more specific PEPFAR expenditures.
Object classes provide highly specific ways that implementing partners are spending PEPFAR funds on programming.
Cross-cutting attributions are areas of PEPFAR programming that contribute across several program areas. They contain limited indicative information related to aspects such as human resources, health infrastructure, or key populations programming. However, they represent only a small proportion of the total funds that PEPFAR allocates through the COP process. Additionally, they have changed significantly over the years. As such, analysis and interpretation of these data should be approached carefully. Learn more
Beneficiary Expenditure data identify how PEPFAR programming is targeted at reaching different populations.
Sub-Beneficiary Expenditure data highlight more specific populations targeted for HIV prevention and treatment interventions.
PEPFAR sets targets using the Monitoring, Evaluation, and Reporting (MER) System - documentation for which can be found on PEPFAR's website at https://www.pepfar.gov/reports/guidance/. As with most data on this website, the targets here have been extracted from the COP documents. Targets are for the fiscal year following each COP year, such that selecting 2016 will access targets for FY2017. This feature is currently experimental and should be used for exploratory purposes only at present.
Years of mechanism: 2012 2013 2014 2015
This mechanism supports CARs PEPFAR Strategy Objective 1.
The goal of the Health Policy Project (HPP) is to improve the enabling environment for MARPs in Central Asia, focusing on identification and reduction of the legal and policy barriers for MARPs to access services. HPP also supports HIV financing as well as capacity development to address gender and stigma-based inequitable access to health services and to improve measurement of policy impacts on health outcomes.
The project will conduct activities in Kazakhstan, Kyrgyzstan and Tajikistan and will work with policymakers, NGOs and most-at-risk populations.
The project will provide short-term targeted TA to implement project activities so there is no need for the project to become more cost-efficient over the longer term.
Most project activities will be assessments and reviews but any materials that are developed will be incorporated into development partner plans or will be shared with other donors including the GFATM.
The project will develop monitoring and evaluation plans for all project activities, which will be reported to and monitored by USG.
This mechanism supports the CARs PEPFAR Strategy Objective 1, with a focus on Sub-objective 1.1 Enabling Environment: Stigma, discrimination, gender, and legal and policy barriers pose significant challenges for HIV prevention, especially for PWID, SW, and MSM. This activity is linked to IDUP BCNs of: (1) PSI/M #12859;(2) Abt Associates/ IM # 12746;(3) Columbia / IM#12872;(4) RAC-KZ/IM #12889; (5) RAC-KG/IM #13217; (6) RNC-KG/IM #12812; (7) TBD Harm Reduction Center/IM #13969;(8) UNODCIM #12772; and HPP/IM #13973. The Ministries of Health (MOHs), USG and other donors currently employ a range of strategies at all levels to help ensure that services are provided for stigmatized and marginalized populations. Through communities, peer outreach approaches are used to efficiently bring HIV services (condoms, information, and referrals) to MARPs. Through service delivery, the USG, GFATM and other donors use vouchers and social escorts, case management teams, training for health providers and salary incentives to improve the quality of services. At the national level, limited policy and advocacy activities have been conducted to improve the legal framework and sensitize policy makers to improve stigma and discrimination.
To develop a more strategic and systematic approach to policy development, the Health Policy Project will conduct a rapid review of policy reviews and assessments completed by the USG and other partners during the last several years. The review will identify any gaps and assist in the development of a strategically-focused policy advocacy agenda, including targeted policy interventions, to guide USG inputs in this area. HPP will assist in the development of focused approaches to engage legislature and parliaments to address MAT issues. HPP will look more closely at policy-related stigma and discrimination in Central Asia. To better inform the MOHs, USG and other development partners, a second rapid review will be conducted in Kazakhstan, Kyrgyzstan and Tajikistan to identify key policy and other barriers constraining MARPs. This review will inform a more strategic approach to addressing stigma and discrimination in all three countries. The project will widely disseminate the findings from the review, and use this information as an advocacy tool for policy makers, NGOs, MARPs and development partners. The project will also identify additional activities that should be conducted by other USG partners to address these barriers. As a result of this review, USG and development partners will be able to more strategically focus limited resources to address these legal and policy barriers.
Strengthening financing of HIV activities is critical to helping to ensure sustainability and country ownership of these programs. The project will provide TA to enable national and local HIV/AIDS stakeholders to analyze, interpret, and utilize costing data, to support policy advocacy efforts, and to assess and promote more effective and efficient resource allocation. The project will introduce a strategic planning model that links national program goals and resource levels to program outcomes and provides information on the cost and effect of different approaches on the achievement of national goals.
The projects activities will be closely coordinated with other USG partners, MOHs, policymakers, development partners and the GFATM to ensure that the findings from the review and HIV financing activities are coordinated and used.
